Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Oldest sequenced RNA reveals details about a mammoth’s final moments 40,000 years - 2Figure out how to Use Your Brain research Degree in the Gig Market
- 3Some Americans say they'll go without health insurance as ACA rates spike
- 4Tesla Stock Hasn’t Looked This Cheap in a While
- 5Manual for 6 Busssiness Class Flights
- Israel strikes Beirut amid rocket fire from Hezbollah and Iran
- 2 ways you can conserve the water used to make your food
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 3 Italian City Cars That Outsmarted Regulations and Rivals
- Home Machine Basics: An Exhaustive Purchasing Guide
- First Alert: Light snow through this evening
- IDF, police arrest eleven for criminal, terror-related activity over weekend
- New studies of old dogs help scientists understand where they came from
- Instructions to Decide whether a Fender bender Legal counselor is Required for Your Particular Case
